Clinical Trial: An Open-label Study With NVC-001 in Patients With LMNA-related Dilated Cardiomyopathy (SUNBEAM-LMNA)

U.S., May 27 -- ClinicalTrials.gov registry received information related to the study (NCT07606274) titled 'An Open-label Study With NVC-001 in Patients With LMNA-related Dilated Cardiomyopathy (SUNBEAM-LMNA)' on May 06.

Brief Summary: This study will be conducted to evaluate the safety and tolerability, and assess exploratory efficacy of NVC-001 in adults participants with LMNA-Related Dilated Cardiomyopathy.

Study Start Date: May 08

Study Type: INTERVENTIONAL

Condition: LMNA-Related Dilated Cardiomyopathy

Intervention: GENETIC: NVC-001 - Low Dose

Solution for intravenous infusion

GENETIC: NVC-001 - Intermediate Dose

Solution for intravenous infusion

GENETIC: NVC-001 - High Dose

Solution for intravenous infusion

Recruitment St...